Skip to main content
CDMFossil fuel switchIndiaAM0029

Grid connected 156.1 MW Combined Cycle Power plant at Hazira, Gujarat

CDM-4419 ↗

#1126of 1329 in Industrial#864of 975 in India#1336of 1459 in CDM (UNFCCC)#17of 19 in AM0029

4.1/ 10
Integrity
4.5
Transparency
4.0
Claim Safety
4.0
Documentation
3.5

Audit Analysis

A CDM fossil-fuel-switch project (156.1 MW combined-cycle gas plant in Gujarat, India) with a VVB-confirmed investment additionality test and a jurisdictional grid-emission-factor baseline, but undermined by 20 material findings at validation, five cross-document contradictions (including a 54% grid-EF discrepancy and a baseline-method conflict), and a first monitoring period that delivered roughly 4.2× the pro-rata ex-ante expectation. The project's core methodology (AM0029) is well-established, yet the volume of unresolved documentation gaps and contradictions materially weakens confidence in the credit quantity and baseline integrity.

Red Flags

  • 20 material findings at validation, including missing DNA approval, inadequate baseline scenario justifications (lignite, nuclear, grid import), and missing financing charges in the cost calculation
  • Grid emission factor discrepancy: the PDD records 593.8 (likely kg CO₂/MWh) while the monitoring report uses 0.9163 t CO₂/MWh (≈916 kg CO₂/MWh), a 54% difference that directly inflates the credit quantity
  • Baseline method contradiction: the validation report describes a 'project' baseline while the monitoring report states 'jurisdictional', creating ambiguity about which baseline was actually applied
  • First monitoring period ERR of 385,292 t CO₂ is approximately 4.2× the pro-rata expectation of ~91,900 t CO₂ derived from the 765,718 t CO₂ lifetime ex-ante estimate, raising over-crediting concerns
  • No buffer pool, no reversal-event tracking, and no quantified leakage percentage are recorded in the available documents

Credit Vintages

IssuedRetiredAvailable
2015
392,5610392,561
Total392,5610392,561

Risk Indicators

Additionality

VVB-confirmed investment test

Permanence

Avoidance project, no reversal risk

Leakage

Quantified but no specific % stated

Baseline

Jurisdictional EF but method contradicted across docs

Safeguards

Mentioned; benefit sharing described; no FPIC or grievance m

Double-claim

CORSIA and CCP status not stated

Where to buy

+ Know where to buy this?

Listing multiple projects? Send us a CSV at [email protected].

⚑ Dispute this rating
Analysis ProvenanceScored2026-08-30AM0029

Are you the project owner?

Metadata correction (free)

Name, country, marketplace or links incorrect? Let us know.

Does not modify the score.

[email protected]

Pipeline re-run with new documents

Have updated documentation not yet included? You can request a new run of the pipeline with the new inputs.

Submit Documents